On October 31, the U.S. District Court for the Eastern District of Virginia granted a preliminary injunction blocking the U.S. Patent Office’s Claims and Continuations Rules from taking effect. While the rules are on hold, nutraceutical companies need to remain informed so they can make decisions that will maximize the value of their patent portfolios during these uncertain times. In her byline on www.nutraingredients-usa.com, Foley’s Courtenay Brinckerhoff highlights some of the arguments by Smithkline Beecham Corporation (GSK), who challenged the court on the rules, as well as the court’s decisions and the possible impact on nutraceutical companies
Click here for the full article.
Author(s)
Related Insights
04 November 2025
Events
Telemedicine Law Nationwide: a 50-State Assessment – MPL Association Corporate Counsel Workshop
Nathaniel Lacktman, partner and chair of Foley’s Telemedicine & Digital Health Industry Team and Chairman of the American Telemedicine Association Board of Directors, will be a speaker at the Medical Professional Liability Association’s annual Corporate Counsel Workshop on November 4-5, 2025.
14 May 2025
Energy Current
DOE Set to Eliminate Presidential Permit Requirement for Cross-Border Transmission Facilities and Streamline Electricity Export Authorizations
On May 12, 2025, the U.S. Department of Energy announced a proposal to streamline the application process for authorizations to transmit electricity from the United States to other countries.
13 May 2025
IP Litigation Current